US WHO Withdrawal Official, Organisation Plans Deep Cuts
The US WHO Withdrawal became final in January 2026, raising risks for flu surveillance, outbreak response, and WHO funding as job cuts loom.
Global Malaria Crisis Deepens Amid US Cuts, Rising Resistance
Global malaria crisis worsens as US aid cuts, rising resistance, and stalled progress put millions, especially children, at deadly risk.
US Drug Prices Under Trump’s New Pharma Deals
Examine the ongoing battle over US drug prices and the potential effects of Trump's recent pharma agreements on affordability.
Obesity Drug Deal: Trump Cuts Prices for Patients
The landmark obesity drug deal announced by Trump aims to make weight management drugs more affordable for millions of patients.
Pfizer Drug Pricing Deal Sees Stocks Soar
Learn about the Pfizer drug pricing deal that has stirred market reactions. Find out why analysts call it "more optics than bite".
HHS Restructuring Plan Blocked by Federal Court
The HHS restructuring plan faced a major setback as the court intervened, stopping job cuts and agency overhaul efforts.
Children’s Lives at Risk as US Proposes Slashing Funds for Gavi
The proposed funding cuts to Gavi put children's lives at risk, threatening global progress in childhood immunisation efforts.
Lower Pharmaceutical Prices: Trump’s Bold Ultimatum
Trump demands lower pharmaceutical prices from major drug companies in a bold move to align US costs with global standards.
USAID Funding Cuts Could Trigger 14 Million Deaths by 2030
USAID funding cuts could cause 14m avoidable deaths by 2030, including 4.5m children under five, warns Lancet study.
Trump’s Tariff Stick Won’t Bring Generic Drug Manufacturing Home
Analyze the implications of Trump's Tariff Stick for the US generics industry. Tariffs might worsen the supply of critical medicines.